Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-08 | Amended | $507,484 | $150,000 | Debt Only | 06b | SEC link |
| 2024-05-08 | New | $357,484 | $357,484 | Debt Only | 06b | SEC link |
| 2021-10-19 | New | $35,000 | $35,000 | Equity Only | 06b | SEC link |
| 2015-03-27 | New | $1,169,025 | $1,169,025 | Equity Only | 06b | SEC link |
| 2014-10-28 | New | $1,545,050 | $1,545,050 | Debt Only | 06b | SEC link |
| 2013-01-29 | Amended | $3,271,712 | $900,000 | Equity Only | 06 | SEC link |
| 2012-03-05 | New | $460,000 | $460,000 | Debt Only | 06 | SEC link |
| 2011-06-06 | New | $2,371,712 | $2,371,712 | Equity Only | 06 | SEC link |
| 2011-01-31 | Amended | $782,000 | $350,000 | Debt Only | 06 | SEC link |
| 2010-07-29 | New | $432,000 | $432,000 | Debt Only | 06 | SEC link |
| Name | Role |
|---|---|
| Robert Boolbol | Director |
| Elizabeth Boolbol | Executive |
| Kenneth M Corroon | Director, Executive |
| Abhaya Kumar Jain | Director |
| Vikesh Kumar | Director |
| David B Mc Kane | Director |
| Daniel R Mc Leod | Director |
| David B Mckane | Director |
| Daniel R Mcleod | Director |
| Jean Paul Wienen | Director |